JP2005213261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005213261A5 JP2005213261A5 JP2005037992A JP2005037992A JP2005213261A5 JP 2005213261 A5 JP2005213261 A5 JP 2005213261A5 JP 2005037992 A JP2005037992 A JP 2005037992A JP 2005037992 A JP2005037992 A JP 2005037992A JP 2005213261 A5 JP2005213261 A5 JP 2005213261A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- preparation according
- total dry
- dry mass
- analgesic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000825 pharmaceutical preparation Substances 0.000 claims 11
- 239000000730 antalgic agent Substances 0.000 claims 4
- 150000002148 esters Chemical class 0.000 claims 3
- 150000002632 lipids Chemical class 0.000 claims 3
- 239000004698 Polyethylene Substances 0.000 claims 2
- 229940035676 analgesics Drugs 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 claims 2
- 150000003904 phospholipids Chemical class 0.000 claims 2
- -1 polyethylene Polymers 0.000 claims 2
- 229920000573 polyethylene Polymers 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 claims 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 239000003012 bilayer membrane Substances 0.000 claims 1
- 229960001259 diclofenac Drugs 0.000 claims 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 229960001680 ibuprofen Drugs 0.000 claims 1
- 229960000905 indomethacin Drugs 0.000 claims 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 claims 1
- 229960000991 ketoprofen Drugs 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 229960002009 naproxen Drugs 0.000 claims 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 claims 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims 1
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims 1
- 239000002736 nonionic surfactant Substances 0.000 claims 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 claims 1
- 229960002702 piroxicam Drugs 0.000 claims 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41784702P | 2002-10-11 | 2002-10-11 | |
| US10/357,618 US20040105881A1 (en) | 2002-10-11 | 2003-02-04 | Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin |
| US10/357,617 US7473432B2 (en) | 2002-10-11 | 2003-02-04 | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005500984A Division JP2006505619A (ja) | 2002-10-11 | 2003-10-09 | 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2005213261A JP2005213261A (ja) | 2005-08-11 |
| JP2005213261A5 true JP2005213261A5 (enExample) | 2007-08-02 |
| JP4555111B2 JP4555111B2 (ja) | 2010-09-29 |
Family
ID=32995875
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005500984A Pending JP2006505619A (ja) | 2002-10-11 | 2003-10-09 | 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体 |
| JP2005037992A Expired - Fee Related JP4555111B2 (ja) | 2002-10-11 | 2005-02-15 | 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体 |
| JP2008283199A Pending JP2009108070A (ja) | 2002-10-11 | 2008-11-04 | 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2005500984A Pending JP2006505619A (ja) | 2002-10-11 | 2003-10-09 | 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008283199A Pending JP2009108070A (ja) | 2002-10-11 | 2008-11-04 | 半透性バリアを介した向上した輸送のための、およびインビボでの、特に皮膚を介した非侵襲性薬剤利用のための、少なくとも３つの両親媒性物質を含む、向上した変形性を備えた凝集体 |
Country Status (21)
| Country | Link |
|---|---|
| EP (5) | EP1815846A3 (enExample) |
| JP (3) | JP2006505619A (enExample) |
| KR (1) | KR20050055723A (enExample) |
| CN (1) | CN1703199B (enExample) |
| AT (1) | ATE381316T1 (enExample) |
| AU (1) | AU2003273977B2 (enExample) |
| BR (1) | BR0315148A (enExample) |
| CA (1) | CA2498938A1 (enExample) |
| DE (1) | DE60318227T2 (enExample) |
| DK (1) | DK1551370T3 (enExample) |
| EA (1) | EA010407B1 (enExample) |
| ES (1) | ES2298566T3 (enExample) |
| HR (1) | HRPK20050421B3 (enExample) |
| IS (1) | IS7776A (enExample) |
| MX (1) | MXPA05003744A (enExample) |
| NO (1) | NO20052281L (enExample) |
| NZ (1) | NZ538571A (enExample) |
| PL (1) | PL377202A1 (enExample) |
| PT (1) | PT1551370E (enExample) |
| SI (1) | SI1551370T1 (enExample) |
| WO (1) | WO2004032900A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1031346B1 (en) | 1999-01-27 | 2002-05-02 | Idea Ag | Noninvasive vaccination through the skin |
| EP1031347B1 (en) | 1999-01-27 | 2002-04-17 | Idea Ag | Transnasal transport/immunisation with highly adaptable carriers |
| WO2001001962A1 (en) | 1999-07-05 | 2001-01-11 | Idea Ag. | A method for the improvement of transport across adaptable semi-permeable barriers |
| DE10053397A1 (de) | 2000-10-20 | 2002-05-02 | Schering Ag | Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen |
| US7473432B2 (en) | 2002-10-11 | 2009-01-06 | Idea Ag | NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery |
| CA2584475A1 (en) * | 2004-11-12 | 2006-05-18 | Idea Ag | Extended surface aggregates in the treatment of skin conditions |
| CA2698293A1 (en) * | 2007-09-13 | 2009-03-26 | Thomas Subkowski | Use of hydrophobin polypeptides as penetration intensifiers |
| PL214538B1 (pl) * | 2009-05-28 | 2013-08-30 | P P F Hasco Lek Spolka Akcyjna | Kompozycja liposomowa zawierajaca naproksen i sposób wytwarzania kompozycji liposomowej zawierajacej naproksen |
| JP2012528846A (ja) * | 2009-06-03 | 2012-11-15 | マヨ、ジョン、チャールズ | 深部組織の痛みを治療するための製剤 |
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| EP2688554A2 (en) * | 2011-03-21 | 2014-01-29 | Gregor Cevc | Optimised preparations of highly adaptable aggregates |
| US20140017301A1 (en) * | 2011-03-21 | 2014-01-16 | Gregor Cevc | Drug-free compositions and methods for diminishing peripheral inflammation and pain |
| GB201205642D0 (en) | 2012-03-29 | 2012-05-16 | Sequessome Technology Holdings Ltd | Vesicular formulations |
| JP6375301B2 (ja) * | 2012-10-26 | 2018-08-15 | オックスフォード ナノポール テクノロジーズ リミテッド | 液滴界面 |
| RU2524649C1 (ru) * | 2013-07-24 | 2014-07-27 | Станислав Анатольевич Кедик | Способ получения микросфер для приготовления инъецируемой лекарственной формы диклофенака, композиция и лекарственная форма |
| SG11201600424VA (en) * | 2013-07-31 | 2016-02-26 | Sequessome Technology Holdings Ltd | Vesicles |
| CN105764917B (zh) * | 2013-09-26 | 2021-10-08 | 新加坡国立大学 | 利用溶血磷脂酰胆碱支架的组合物和方法 |
| CN105658782B (zh) * | 2013-10-25 | 2018-08-07 | 凸版印刷株式会社 | 膜囊泡回收设备、膜囊泡回收方法及膜囊泡分析方法 |
| US10744090B2 (en) | 2015-06-30 | 2020-08-18 | Sequessome Technology Holdings Limited | Multiphasic compositions |
| EP3377043A4 (en) | 2015-11-20 | 2019-06-26 | The Regents of The University of California | DEVICABLE NANOSCAL CARRIER (DNVS) FOR ADMINISTRATION THROUGH THE BLOOD-BRAIN-BARRIER, MICE AND SKIN |
| CN110662532A (zh) * | 2017-04-03 | 2020-01-07 | 加利福尼亚大学董事会 | 用于跨血脑屏障、透粘膜和经皮药物递送的可变形的纳米级媒介物(dnvs) |
| GB2571696B (en) | 2017-10-09 | 2020-05-27 | Compass Pathways Ltd | Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced |
| KR102149190B1 (ko) | 2018-04-09 | 2020-08-28 | 경상대학교산학협력단 | 액중 방전 마이크로젯 약물 전달장치 |
| KR20220008824A (ko) | 2019-04-17 | 2022-01-21 | 컴퍼스 패쓰파인더 리미티드 | 실로시빈으로 불안 장애, 두통 장애 및 섭식 장애를 치료하는 방법 |
| IL312785B2 (en) | 2020-05-19 | 2026-06-01 | Cybin Irl Ltd | Deuterated tryptamine derivatives and methods of use |
| KR102209397B1 (ko) | 2020-07-21 | 2021-01-29 | 경상대학교산학협력단 | 액중 방전 마이크로젯 약물 전달장치 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3765579B2 (ja) * | 1990-08-24 | 2006-04-12 | イーデーエーアー アーゲー | 作用物質投与用超微小滴状調剤 |
| DE4107153A1 (de) * | 1991-03-06 | 1992-09-10 | Gregor Cevc | Praeparat zur wirkstoffapplikation in kleinsttroepfchenform |
| US6165500A (en) * | 1990-08-24 | 2000-12-26 | Idea Ag | Preparation for the application of agents in mini-droplets |
| DE4447287C1 (de) * | 1994-12-30 | 1996-11-07 | Cevc Gregor | Präparat zum Wirkstofftransport durch Barrieren |
| US20020048596A1 (en) * | 1994-12-30 | 2002-04-25 | Gregor Cevc | Preparation for the transport of an active substance across barriers |
| CZ20012038A3 (cs) * | 1998-12-23 | 2001-09-12 | Idea Ag | Zdokonalený přípravek pro topické, neinvazivní použití in vivo |
| EP1031347B1 (en) * | 1999-01-27 | 2002-04-17 | Idea Ag | Transnasal transport/immunisation with highly adaptable carriers |
-
2003
- 2003-10-09 NZ NZ538571A patent/NZ538571A/en not_active IP Right Cessation
- 2003-10-09 PL PL377202A patent/PL377202A1/pl not_active Application Discontinuation
- 2003-10-09 EP EP06023465A patent/EP1815846A3/en not_active Withdrawn
- 2003-10-09 DK DK03757944T patent/DK1551370T3/da active
- 2003-10-09 EP EP03757944A patent/EP1551370B1/en not_active Expired - Lifetime
- 2003-10-09 WO PCT/EP2003/011202 patent/WO2004032900A1/en not_active Ceased
- 2003-10-09 SI SI200331142T patent/SI1551370T1/sl unknown
- 2003-10-09 AT AT03757944T patent/ATE381316T1/de active
- 2003-10-09 PT PT03757944T patent/PT1551370E/pt unknown
- 2003-10-09 EP EP06023466A patent/EP1829527A3/en not_active Withdrawn
- 2003-10-09 EA EA200500632A patent/EA010407B1/ru not_active IP Right Cessation
- 2003-10-09 HR HR20050421A patent/HRPK20050421B3/xx not_active IP Right Cessation
- 2003-10-09 ES ES03757944T patent/ES2298566T3/es not_active Expired - Lifetime
- 2003-10-09 MX MXPA05003744A patent/MXPA05003744A/es active IP Right Grant
- 2003-10-09 EP EP06023468A patent/EP1815847A3/en not_active Withdrawn
- 2003-10-09 AU AU2003273977A patent/AU2003273977B2/en not_active Ceased
- 2003-10-09 JP JP2005500984A patent/JP2006505619A/ja active Pending
- 2003-10-09 EP EP06023467A patent/EP1829528A3/en not_active Withdrawn
- 2003-10-09 CA CA002498938A patent/CA2498938A1/en not_active Abandoned
- 2003-10-09 CN CN2003801013013A patent/CN1703199B/zh not_active Expired - Fee Related
- 2003-10-09 DE DE60318227T patent/DE60318227T2/de not_active Expired - Lifetime
- 2003-10-09 BR BR0315148-4A patent/BR0315148A/pt not_active IP Right Cessation
- 2003-10-09 KR KR1020057004979A patent/KR20050055723A/ko not_active Ceased
-
2005
- 2005-02-15 JP JP2005037992A patent/JP4555111B2/ja not_active Expired - Fee Related
- 2005-03-30 IS IS7776A patent/IS7776A/is unknown
- 2005-05-10 NO NO20052281A patent/NO20052281L/no not_active Application Discontinuation
-
2008
- 2008-11-04 JP JP2008283199A patent/JP2009108070A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6305973B2 (ja) | 非ステロイド性抗炎症薬の徐放性処方物 | |
| Illes et al. | Exosome-coated metal–organic framework nanoparticles: an efficient drug delivery platform | |
| Shelke et al. | Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies | |
| Ramana et al. | Development of a liposomal nanodelivery system for nevirapine | |
| Mehta et al. | Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes | |
| JP2013540824A5 (enExample) | ||
| JP2010532358A (ja) | 咀嚼可能外層を有する配合剤 | |
| JP6415518B2 (ja) | 制御放出粘膜付着システム | |
| Abdelbari et al. | Implementing nanovesicles for boosting the skin permeation of non-steroidal anti-inflammatory drugs | |
| JP2015520235A5 (enExample) | ||
| US11707436B2 (en) | Methods of treating inflammatory disorders and global inflammation with compositions comprising phospholipid nanoparticle encapsulations of NSAIDS | |
| RU2005108611A (ru) | Дозированные формы модифицированного высвобождения с двумя ядрами | |
| Tangso et al. | Formation of liquid-crystalline structures in the bile salt–chitosan system and triggered release from lamellar phase bile salt–chitosan capsules | |
| JP2008531693A5 (enExample) | ||
| RU2014116821A (ru) | Пластырь с регулируемой окклюзией | |
| da Silva Leite et al. | New perspectives in drug delivery systems for the treatment of tuberculosis | |
| Alam et al. | A microemulsion-based gel of isotretinoin and erythromycin estolate for the management of acne | |
| Shanmugam et al. | Nanostructured self assembled lipid materials for drug delivery and tissue engineering | |
| Abd Elrady et al. | Enhanced buccal bioavailability of olmesartan through ultradeformable bilosomes loaded film: a novel approach for hypertension management | |
| Gupta et al. | Proniosomal powder of captopril: formulation and evaluation | |
| KR20230138946A (ko) | 난수용성 극성 용질을 위한 완전히 희석 가능한 자가마이크로유화 전달 시스템(smedds) | |
| CN102764456A (zh) | 血管栓塞剂及其用途、制备方法 | |
| Rita et al. | Preparation and evaluation of modified proniosomal gel for localised urticaria and optimisation by statistical method | |
| EP0999827A1 (fr) | Nouveaux vecteurs liposomaux de principes actifs | |
| JP2007326877A5 (enExample) |